ISL1 predicts poor outcomes for patients
with gastric cancer and drives tumor
progression through binding to the ZEB1
promoter together with SETD7
Guo T, Wen XZ, Li ZY, Han HB, Zhang CG, Bai YH, Xing XF, Cheng XJ, Du H, Hu Y, Wang XH, Jia YN, Nie ML, Xie M, Li QD, Ji...
· 季加孚
Illumina sequencing ChIP-seq/RNA-seq 表观线 IF 9.685 Cell Death & Disease